Profile data is unavailable for this security.
About the company
Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.
- Revenue in HKD (TTM)34.62bn
- Net income in HKD4.41bn
- Incorporated2000
- Employees23.06k
- LocationSino Biopharmaceutical LtdUnit 09, 41F, Office TowerConvention Plaza, No. 1 Harbour RoadWanchai Hong KongHKG
- Phone+852 28029886
- Fax+852 28800847
- Websitehttps://www.sinobiopharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurocrine Biosciences Inc | 22.36bn | 3.74bn | 97.36bn | 2.00k | 26.62 | 3.82 | 24.49 | 4.35 | 4.66 | 4.66 | 27.91 | 32.50 | 0.6851 | 0.8244 | 4.91 | 1,430,250.00 | 11.46 | 9.00 | 13.48 | 10.78 | 98.18 | 98.32 | 16.73 | 13.51 | 3.30 | -- | 0.00 | -- | 21.45 | 22.29 | 40.23 | 3.28 | 25.55 | -- |
| Elanco Animal Health Inc | 35.88bn | 281.37m | 97.59bn | 9.00k | 350.88 | 1.85 | 17.69 | 2.72 | 0.0716 | 0.0716 | 9.23 | 13.58 | 0.3422 | 1.24 | 5.30 | 510,111.10 | 0.2683 | -2.71 | 0.2993 | -3.02 | 54.96 | 54.72 | 0.7841 | -9.52 | 1.23 | 1.30 | 0.3735 | -- | 0.4981 | 7.65 | 127.46 | 37.85 | -3.99 | -- |
| Financiere de Tubize SA | 0.00 | 860.27m | 98.27bn | -- | 114.23 | 5.47 | 114.23 | -- | 2.08 | 2.08 | 0.00 | 43.49 | 0.00 | -- | -- | -- | 4.81 | 5.68 | 4.85 | 5.89 | -- | -- | -- | 230.34 | -- | -- | 0.00 | 30.18 | -- | -- | 2.22 | -20.50 | -- | 10.90 |
| BridgeBio Pharma Inc | 2.77bn | -6.23bn | 113.34bn | 725.00 | -- | -- | -- | 40.99 | -4.19 | -4.19 | 1.86 | -10.03 | 0.4254 | -- | -- | 487,972.40 | -96.88 | -75.74 | -125.35 | -94.24 | 95.78 | 96.67 | -227.74 | -716.92 | 3.76 | -2.89 | 3.52 | -- | 2,285.27 | 40.48 | 16.70 | -- | 11.63 | -- |
| Zhangzhou Pientzhng Phrmctcl Co Ltd | 11.06bn | 2.74bn | 114.35bn | 2.84k | 41.77 | 6.98 | -- | 10.34 | 4.01 | 4.01 | 16.21 | 23.99 | 0.5515 | 1.15 | 11.11 | 3,444,842.00 | 13.60 | 18.53 | 16.58 | 23.24 | 36.98 | 45.91 | 24.65 | 28.42 | 2.12 | -- | 0.0658 | 42.26 | 7.25 | 13.52 | 6.42 | 16.72 | 74.81 | 29.36 |
| CSPC Pharmaceutical Group Ltd | 29.69bn | 4.60bn | 116.49bn | 19.27k | 25.17 | -- | 54.94 | 3.92 | 0.4017 | 0.4017 | 2.59 | -- | -- | -- | -- | 1,387,379.00 | -- | 14.64 | -- | 19.49 | 66.23 | 72.50 | 15.54 | 19.11 | -- | -- | -- | 41.10 | -7.76 | 5.59 | -26.31 | 3.11 | 4.76 | 21.28 |
| Torrent Pharmaceuticals Ltd | 11.00bn | 1.96bn | 119.13bn | 16.11k | 60.76 | -- | 44.75 | 10.83 | 67.12 | 67.12 | 376.38 | -- | -- | -- | -- | 7,910,902.00 | -- | 9.54 | -- | 14.72 | 75.64 | 72.56 | 17.83 | 14.14 | -- | 16.34 | -- | 61.09 | 7.35 | 7.72 | 15.39 | 14.48 | 8.51 | 30.36 |
| Ipsen SA | 36.45bn | 4.11bn | 120.28bn | 5.36k | 29.08 | 2.95 | 10.72 | 3.30 | 5.32 | 5.32 | 47.09 | 52.42 | 0.5875 | 2.85 | 5.30 | -- | 6.66 | 9.15 | 8.54 | 12.07 | 80.89 | 82.61 | 11.33 | 15.86 | 1.79 | 122.28 | 0.1845 | -- | 9.92 | 7.90 | 24.61 | -4.01 | 18.50 | -- |
| Sino Biopharmaceutical Ltd | 34.62bn | 4.41bn | 122.32bn | 23.06k | 26.65 | 3.09 | 13.29 | 3.53 | 0.2446 | 0.243 | 1.91 | 2.11 | 0.4317 | 2.83 | 3.98 | 1,420,047.00 | 9.56 | 12.16 | 18.52 | 20.91 | 81.77 | 80.75 | 22.15 | 26.50 | 1.28 | -- | 0.2071 | 27.19 | 10.18 | 3.56 | 3.93 | -7.01 | -7.91 | 6.66 |
| Swedish Orphan Biovitrum AB (publ) | 24.73bn | 418.71m | 127.61bn | 1.89k | 314.31 | 3.74 | 36.79 | 5.16 | 1.30 | 1.30 | 81.42 | 109.12 | 0.3953 | 1.28 | 5.11 | 14,956,040.00 | 0.6663 | 3.92 | 0.8337 | 5.04 | 78.89 | 77.84 | 1.69 | 10.91 | 0.585 | 9.77 | 0.2336 | 0.00 | 8.50 | 13.10 | -87.70 | -31.82 | -3.93 | -- |
| Moderna Inc | 15.19bn | -22.06bn | 128.95bn | 5.80k | -- | 1.91 | -- | 8.49 | -7.26 | -7.26 | 5.00 | 22.14 | 0.1468 | 5.34 | 7.17 | -- | -21.31 | 10.19 | -25.32 | 13.43 | 62.91 | 75.16 | -145.16 | 19.02 | 3.22 | -- | 0.0659 | -- | -39.93 | 19.33 | 20.75 | -- | 24.53 | -- |
| Sichuan Biokin Pharmaceutical Co Ltd | 2.52bn | -964.32m | 134.06bn | 2.52k | -- | 16.52 | -- | 53.23 | -2.14 | -2.14 | 5.54 | 17.37 | 0.2309 | 1.44 | 2.31 | 883,003.90 | -8.84 | 27.12 | -11.31 | 47.59 | 89.15 | 86.86 | -38.29 | 29.03 | 5.23 | -- | 0.3446 | 0.00 | 936.31 | 37.00 | 575.02 | 243.69 | 31.86 | -- |
| Divi's Laboratories Ltd | 8.90bn | 2.14bn | 141.34bn | 18.30k | 66.01 | -- | 55.91 | 15.88 | 93.45 | 93.45 | 388.82 | -- | -- | -- | -- | 5,636,066.00 | -- | 15.81 | -- | 17.33 | 61.65 | 55.90 | 24.04 | 25.82 | -- | -- | -- | 35.19 | 19.31 | 11.65 | 36.94 | 9.74 | 3.98 | 13.40 |
| Viatris Inc | 110.40bn | -28.85bn | 141.96bn | 32.00k | -- | 1.20 | -- | 1.29 | -3.10 | -3.10 | 11.96 | 13.13 | 0.3417 | 2.09 | 4.90 | 441,387.50 | -8.93 | -0.1756 | -10.89 | -0.2096 | 39.36 | 40.66 | -26.13 | -0.5768 | 0.793 | 2.79 | 0.4868 | -- | -4.46 | 5.09 | -1,259.42 | -- | -3.10 | -- |
Data as of Feb 13 2026. Currency figures normalised to Sino Biopharmaceutical Ltd's reporting currency: Hong Kong Dollar HKD
8.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 07 Jan 2026 | 377.16m | 2.01% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 203.58m | 1.09% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 197.02m | 1.05% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 140.18m | 0.75% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 134.22m | 0.72% |
| BlackRock Advisors (UK) Ltd.as of 09 Jan 2026 | 115.73m | 0.62% |
| Artemis Investment Management LLPas of 29 Aug 2025 | 102.42m | 0.55% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 99.08m | 0.53% |
| Hang Seng Investment Management Ltd.as of 09 Jan 2026 | 96.27m | 0.51% |
| The Caisse de d�p�t et placement du Qu�becas of 31 Dec 2024 | 88.78m | 0.47% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
